VYGR
Voyager Therapeutics Inc
2.50$
-8.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 238.3% | -298.7% | -605.3% | -208.5% | 46.6% | -56.5% | -143.1% | -30.6% | 31.2% | -19.1% | -328.1% | |
| – | 3.5% | 4.3% | 15.7% | 27.8% | 2.6% | 2.2% | 13.8% | 15.1% | 1.8% | 5.9% | 10.1% | |
| – | 23.2% | 44.4% | 91.1% | 206.2% | 15.0% | 8.7% | 30.3% | 22.8% | 4.5% | 18.5% | 36.6% | |
| – | 93.9% | 62.6% | 92.5% | 217.5% | 13.4% | 8.7% | 30.3% | 23.8% | – | – | – | |
| – | 323.9% | -90.4% | -21.1% | 726.9% | 75.1% | -84.5% | 8.8% | 50.0% | -26.6% | 43.6% | -71.2% | |
| – | 5.9% | 35.4% | 39.3% | 56.5% | 7.4% | 7.1% | 4.3% | 6.1% | 1.3% | 4.4% | 6.4% | |
| – | -1,123.6% | 332.6% | -36.3% | 347.4% | -86.7% | 66.0% | 176.1% | -17.9% | -56.7% | -118.6% | 310.7% | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 604.5% | 3.6% | 5.6% | 11.3% | 0.6% | 0.5% | 1.6% | 1.2% | – | 24.1% | – | |
| – | 1,025.4% | 3.6% | 591.2% | 62.3% | 77.6% | 1.8% | 1.6% | 2.7% | 13.5% | 142.5% | 2.0% | |
| – | 140.0% | 37.5% | -50.4% | 201.2% | 37.5% | 10.8% | 34.7% | -45.2% | -12.0% | 4.8% | -15.4% | |
| – | 232.3% | -334.1% | -644.6% | -265.0% | 39.2% | -63.6% | -147.4% | -36.7% | 29.9% | -23.5% | -334.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.